InHealth Precision Medicine Society

05/08/2022

Dr. Stevens will be delivering a talk titled “The Pathway to Precision Medicine in Intensive Care.” He is an intensive care physician who treats patients with critical surgical and neurological illnesses and injuries. Dr. Stevens has special expertise in the care of traumatic brain injury, stroke, encephalopathy, and in the management of patients after cardiac arrest. He is the Director of Precision Medicine and Chief of the Division of Informatics, Integration and Innovation in the Department of Anesthesiology and Critical Care Medicine. He also serves as Associate Director of the Johns Hopkins Precision Medicine Center of Excellence in Neurocritical Care. Join us for a live talk on how precision medicine can be leveraged in the ICU setting to lower healthcare costs and improve patient outcomes. In addition, come learn about how you can get involved in the executive board of the InHealth Precision Medicine Society for next year. Since this is an in-person event, please RSVP using the Eventbrite link below to secure your spot. We hope to see you there!

Dr. Stevens will be delivering a talk titled “The Pathway to Precision Medicine in Intensive Care”

04/26/2022

We are hosting Dr. Nickolas Papadopolous tomorrow at 5pm who will be presenting a talk titled "Early Detection of Cancer: Challenges and Opportunities." Dr. Nickolas Papadopoulos is a Professor of Oncology and Pathology at the Johns Hopkins University School of Medicine. His research focuses on cancer biology, genetics and diagnostics. Dr. Papadopoulos is internationally known as a co‐discoverer of the genetic basis of the predisposition to hereditary nonpolyposis colon cancer (HNPCC), one of the most common hereditary forms of cancer. He was part of a team that was first to sequence all protein coding genes, determine genetic alterations and construct expression profiles of four common tumor types. His noteworthy discoveries include the identification of novel mutations in chromatin remodeling genes in ovarian clear cell carcinomas and pancreatic neuroendocrine tumors.

More recently, he has been engaged in translating the genetic information derived from cancer genome analyses to clinical applications in early detection, diagnosis and monitoring of cancer. He is a co-developer of sensitive methods for the detection of tumor DNA in liquid biopsy. Dr. Papadopoulos developed CancerSEEK, an innovative blood test designated as a "breakthrough device" by the FDA for early detection of cancer, and he is the co-founder of two biotech companies that develop diagnostics for cancer. Sign up to learn more about the progress and prospects of implementing a non-invasive liquid biopsy in the clinical setting for early multi-cancer detection!

04/09/2022

Dr. Olivier Elemento will be presenting a talk entitled "Towards AI-driven precision medicine" on Friday, April 15 at 5 pm. Dr. Elemento is the Director of the Englander Institute for Precision Medicine, Associate Director of the Institute for Computational Biomedicine, and a Professor of Physiology and Biophysics at Weill Cornell Medicine. His work focuses on Big Data analytics for precision oncology applications, including gene regulation in cancer cells, computational algorithms for identifying new cancer mutations, cancer epigenomics, and tumor genome evolution. His group developed the first whole exome sequencing test for cancer cells approved by New York State and a recent thyroid cancer detection algorithm. Use the link below to register or scan the QR code!

https://jhubluejays.zoom.us/meeting/register/tJcvcuGvpjwoE9Nnx6V2ypJZKVkWyDBHM07h

03/29/2022

Check out our blog “Bringing Precision Medicine into COVID-19 ICUs” to learn more about the Severe COVID-19 Adaptive Risk Predictor using the link in the bio!⚕️

03/09/2022

Developing Technologies to Decipher the Role of Hypoxia in Breast Cancer Metastasis — a talk by Dr. Daniele Gilkes, Assistant Professor of Oncology. This upcoming event is hosted on March 11th at 5 PM!!

09/26/2021

On October 14, we will be hosting a talk by Dr. Scott Zeger, a professor of biostatistics at the Johns Hopkins Bloomberg School of Public Health and a faculty member of the Malone Center for Engineering in Healthcare at the Whiting School of Engineering. The talk is titled "Harnessing Biotechnology, Data and Communication Revolutions to Improve Patient Outcomes at More Affordable Costs." Join us for what will be a fascinating primer to this emerging frontier in healthcare. For this event, we are limited to 50 attendees so please RSVP as soon as possible to secure your spot using the following link:

The inHealth Precision Medicine Society at Johns Hopkins is pleased to host Dr. Scott Zeger, Co-Director of the JH inHealth Initiative.

08/28/2021

If you are interested in joining us, use the QR code or head over to https://forms.gle/tbBXzXgabLie12jRA and fill out the information!

08/27/2021

Check out the video below to hear what we are all about!

There is precision medicine, and then there is a whole-person approach to precision medicine. See what sets Johns Hopkins apart at https://www.HopkinsMedicin...